Galectin Therapeutics Inc (NASDAQ:GALT)

Data as of Jan 23
 +0.19 / +5.90%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues0.
Operating ExpensesGross Income-12.0K-9.0K-9.0K-12.0K
Total Operating Expenses4.9M10.4M9.9M12.1M
Non-Operating ExpensesOperating Income-4.9M-10.4M-9.9M-12.1M
Extraordinary Credit0.000.00200.0K0.00
Extraordinary Charge-1.2M-524.0K0.000.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.6M-10.9M-9.7M-12.1M
Preferred Dividend-3.1M-1.8M-976.0K-867.0K
Net Income-5.6M-10.9M-9.9M-21.1M
Shares To Calculate EPSShares To Calculate EPS9.4M12.0M15.1M16.9M
Shares To Calculate EPS Diluted9.4M12.0M15.1M16.9M
Earnings Per ShareEPS-$0.90-$6.36-$0.72-$1.30
EPS Diluted----------

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.